genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2021
Erectile dysfunction
Drug Discovery
Study Suggests Erectile Dysfunction Drug May Lower Risk of Alzheimer’s
Cancer
Prostate Cancer Treatment Goes Nanogold
Drug Discovery
Erectile Dysfunction Drug Protects against Progression of Heart Failure
Industry News
Eli Lilly to Eliminate 3500 Jobs; Close Shanghai, New Jersey R&D Operations
Drug Discovery
Ferring Buys Ex-U.S. Rights to Commercialize ED Cream from Apricus
Drug Discovery
UPDATE: Endo Terminates Agreements with VIVUS, Acerus
News
Blue Light Might Outshine the Little Blue Pill
News
Auxilium Licenses Stendra from Vivus for Up to $300M
News
EC Follows FDA and Approves Lilly’s Erectile Dysfunction Drug for BPH
Cancer
ED Markers Get a Rise from Researchers
1
2
3
Page 1 of 3
Scroll Up
Scroll Up
